Table 1.
Demographics by LCK expression level
| Total cohorta 520 |
LCK highb n = 23 |
Non-LCK high n = 497 | p value |
|---|---|---|---|
| Characteristic | |||
| Age (median) | 40–78 (58) | 30–89 (59) | 0.837 |
| ECOG performance | |||
| 0 | 4 | 69 | 0.633 |
| 1 | 3 | 72 | |
| 2 | 2 | 21 | |
| 3 | 0 | 4 | |
| Unknown | 14 | 331 | |
| Stage | |||
| I | 1 | 15 | 0.134 |
| II | 3 | 25 | |
| IIIA, B | 3 | 28 | |
| IIIC | 13 | 366 | |
| IV | 3 | 80 | |
| Unknown | 0 | 4 | |
| Grade | |||
| 1 | 0 | 5 | 0.552 |
| 2 | 3 | 61 | |
| 3 | 19 | 419 | |
| Unknown | 1 | 12 | |
| Race/ethnicity | |||
| Asian | 1 | 14 | 0.4696 |
| Black | 0 | 23 | |
| Hispanic | 1 | 7 | |
| White | 20 | 433 | |
| Other/unknown | 1 | 20 | |
a520 patients included for a total of 535 samples available
bLC- high: expression > 1.86SD within TCGA ovarian serous cystadenocarcinoma study (TCGA, provisional)